Dechra Pharmaceuticals’ share price hits record peaks! Is it a top UK share to buy?

The Dechra Pharmaceuticals share price has just risen to new all-time highs. Here’s why I think it’s a good buy today.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The Dechra Pharmaceuticals (LSE: DPH) share price has been steadily improving in health during the past year. The business — which manufactures medicines for both companion animals and livestock — has risen 52% in value since early June 2020. This UK healthcare share hit fresh record peaks of £43.20 on Tuesday too, after it released fresh trading news.

Dechra’s share price settled lower and it closed Tuesday’s session at £42.52. Still, this represented a healthy 3% rise on the day. And I think the FTSE 250 company will continue to climb in value.

Sales tipped to beat estimates

In its latest sunny update, Dechra announced that trading for the full year to June 30 is likely to beat market expectations.

Should you invest £1,000 in Unilever right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Unilever made the list?

See the 6 stocks

In February it advised that it had experienced a “strong performance” for the first seven months of financial 2021. And yesterday Dechra said it has “continued to benefit from strong market fundamentals as well as lower underlying selling, general and administration costs” following the Covid-19 outbreak.

Pre-Brexit stockpiles of its medicines are set to finish unwinding and coronavirus restrictions are on course to keep easing. So, Dechra “is increasingly confident that this strong performance will continue for the rest of this financial year.”

The UK share said full-year revenue is likely to exceed current consensus predictions, therefore. Trading is likely to be more evenly distributed than previously guided between the first and second halves of the financial year too.

Profits surge drives Dechra’s share price

Dechra Pharmaceuticals’ share price has exploded in recent years. A strong record of annual earnings growth has seen the FTSE 250 share rise 310% in value over the past half a decade. And City analysts are expecting profits at the business to continue rising at a swift pace.

The number crunchers reckon that earnings will rise 11% in the financial year to June 2021. And they’re forecasting a 7% bottom-line advance in fiscal 2022.

It’s worth bearing in mind that Dechra trades on an elevated forward price-to-earnings (P/E) ratio of 39 times. This increases the chances of a share price correction should news flow around the company begin to disappoint. This could include problems with medicines R&D, a not uncommon problem in the pharma industry that can result in large extra costs and lost revenues.

Why I’d buy this UK share

That being said, I still think Dechra is a good buy, even at today’s high price. This is because the veterinary medicines market is expected to keep on growing rapidly. Analysts at Grand View Research expect it to expand at a compound annual growth rate of 7.4% through to 2028. They reckon this will be driven by “rising R&D and procedural advancements, pet adoption rate, and increasing consumption of meats and mandatory vaccination.”

And I think Dechra, with its broad stable of products and healthy product pipeline, is well placed to exploit this booming industry.

Should you buy Unilever now?

Don’t make any big decisions yet.

Because Mark Rogers — The Motley Fool UK’s Director of Investing — has revealed 5 Shares for the Future of Energy.

And he believes they could bring spectacular returns over the next decade.

Since the war in Ukraine, nations everywhere are scrambling for energy independence, he says. Meanwhile, they’re hellbent on achieving net zero emissions. No guarantees, but history shows...

When such enormous changes hit a big industry, informed investors can potentially get rich.

So, with his new report, Mark’s aiming to put more investors in this enviable position.

Click the button below to find out how you can get your hands on the full report now, and as a thank you for your interest, we’ll send you one of the five picks — absolutely free!

Grab your FREE Energy recommendation now

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Pound coins for sale — 51 pence?

This seems ridiculous, but we almost never see shares looking this cheap. Yet this recent ‘Best Buy Now’ has a price/book ratio of 0.51. In plain English, this means that investors effectively get in on a business that holds £1 of assets for every 51p they invest!

Of course, this is the stock market where money is always at risk — these valuations can change and there are no guarantees. But some risks are a LOT more interesting than others, and at The Motley Fool we believe this company is amongst them.

What’s more, it currently boasts a stellar dividend yield of around 8.5%, and right now it’s possible for investors to jump aboard at near-historic lows. Want to get the name for yourself?

See the full investment case

More on Investing Articles

Investing Articles

How much do investors need in an ISA to earn a £2,500 monthly passive income?

Charlie Carman explores how investors could strive for £30k in tax-free passive income each year from a dividend stock portfolio.

Read more »

Investing Articles

How much would a 45-year-old need to invest in an ISA to earn a £1k monthly passive income at 65?

Harvey Jones looks at how much an investor would need to put away every month to build a steady passive…

Read more »

Investing Articles

3 things to do ahead of the new 2025-26 ISA year

It's time for us all to put on our investing boots and get to work on developing our plans for…

Read more »

Older couple walking in park
Investing Articles

Is £150,000 enough to generate £1,000 a month in passive income?

Stephen Wright takes a look at three UK stocks with dividend yields above 8% that passive income investors might be…

Read more »

Investing Articles

Aim to earn a £50k second income in retirement by investing just this much each month

Even with a small monthly investment, it’s possible to earn a £50k second income with a successful investment strategy and…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

Down 22% in a month! Is this my chance to buy shares in this FTSE 100 outperformer?

Shares in InterContinental Hotels Group have outperformed the FTSE 100 over the long term. So is a chance to buy…

Read more »

Investing Articles

How much would Tesla stock be worth if it was valued like Nvidia?

The market seems to view Tesla as a tech stock rather than a car manufacturer. What could this mean for…

Read more »

Investing Articles

This ex-penny stock skyrocketed 900% in 2020! Is it about to surge again?

This subdued hydrogen penny stock was hot in 2020, but with demand for green hydrogen rising in Europe, can the…

Read more »